Jeff Allen

2.6k total citations
40 papers, 805 citations indexed

About

Jeff Allen is a scholar working on Economics and Econometrics, Oncology and Cancer Research. According to data from OpenAlex, Jeff Allen has authored 40 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Economics and Econometrics, 15 papers in Oncology and 14 papers in Cancer Research. Recurrent topics in Jeff Allen's work include Cancer Genomics and Diagnostics (14 papers), Health Systems, Economic Evaluations, Quality of Life (13 papers) and Lung Cancer Treatments and Mutations (11 papers). Jeff Allen is often cited by papers focused on Cancer Genomics and Diagnostics (14 papers), Health Systems, Economic Evaluations, Quality of Life (13 papers) and Lung Cancer Treatments and Mutations (11 papers). Jeff Allen collaborates with scholars based in United States, United Kingdom and Canada. Jeff Allen's co-authors include Ellen V. Sigal, Samantha Roberts, Mark Stewart, Jay H. Hoofnagle, Leonard B. Seeff, Doris B. Strader, Bruce R. Bacon, Timothy R. Morgan, Karen L. Lindsay and Elizabeth C. Wright and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Nature Reviews Drug Discovery.

In The Last Decade

Jeff Allen

35 papers receiving 763 citations

Peers

Jeff Allen
Hiroshi Ishiguro Japan
Ariadna Tibau Spain
Linyong Xu China
Harald Enzmann Germany
Kelloff Gj United States
Dinesh P. de Alwis United States
Brigitte Tranchand France
John Duan United States
James Matcham United Kingdom
Connie M. Szczepanek United States
Hiroshi Ishiguro Japan
Jeff Allen
Citations per year, relative to Jeff Allen Jeff Allen (= 1×) peers Hiroshi Ishiguro

Countries citing papers authored by Jeff Allen

Since Specialization
Citations

This map shows the geographic impact of Jeff Allen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff Allen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff Allen more than expected).

Fields of papers citing papers by Jeff Allen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeff Allen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff Allen. The network helps show where Jeff Allen may publish in the future.

Co-authorship network of co-authors of Jeff Allen

This figure shows the co-authorship network connecting the top 25 collaborators of Jeff Allen. A scholar is included among the top collaborators of Jeff Allen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeff Allen. Jeff Allen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Allen, Jeff, et al.. (2025). Hurry Up and Wait: Timelines and Takeaways from the Biomarker Qualification Program. Therapeutic Innovation & Regulatory Science. 60(1). 302–308.
2.
3.
Stewart, Mark, et al.. (2025). Companion Diagnostic FDA Review Flexibilities: An Assessment of CDx for NSCLC to Support Aligned Approaches for Validation. Therapeutic Innovation & Regulatory Science. 59(4). 676–679.
4.
Stewart, Mark, Christopher R. Cabanski, Jeff Allen, et al.. (2025). Enabling access to genetically modified cell therapies through flexible approaches to manufacturing and cost recovery. Journal for ImmunoTherapy of Cancer. 13(12). e013518–e013518.
5.
Stewart, Mark, et al.. (2024). Bridging research and practice: enhancing regulatory decisions with pragmatic clinical trials in oncology. SHILAP Revista de lepidopterología. 6. 100065–100065. 1 indexed citations
6.
Baehner, Frederick L., James Chen, Carin R. Espenschied, et al.. (2024). Advancing Evidence Generation for Circulating Tumor DNA: Lessons Learned from A Multi-Assay Study of Baseline Circulating Tumor DNA Levels across Cancer Types and Stages. Diagnostics. 14(9). 912–912. 1 indexed citations
7.
Tygier, Sam, Jeff Allen, Genoveva Burca, et al.. (2023). Tomographic reconstruction with Mantid Imaging. Journal of Physics Conference Series. 2605(1). 12017–12017. 5 indexed citations
8.
9.
Stewart, Mark, et al.. (2020). A National Assessment of Diagnostic Test Use for Patients with Advanced NSCLC and Factors Influencing Physician Decision-Making.. PubMed Central. 13(3). 110–119. 4 indexed citations
10.
Stewart, Mark, Lisa H. Butterfield, Bruce L. Levine, et al.. (2020). Accelerating the development of innovative cellular therapy products for the treatment of cancer. Cytotherapy. 22(5). 239–246. 7 indexed citations
11.
Campbell, Alicyn, Ethan Basch, Stacie Hudgens, et al.. (2020). Use of Patient-Reported Outcomes to Understand & Measure the Patient Experience of Novel Cell and Gene Therapies. Therapeutic Innovation & Regulatory Science. 54(6). 1566–1575. 7 indexed citations
12.
Connors, Dana E., Jeff Allen, Jennifer Boyle, et al.. (2020). International liquid biopsy standardization alliance white paper. Critical Reviews in Oncology/Hematology. 156. 103112–103112. 70 indexed citations
13.
Bonomi, Philip, Gideon M. Blumenthal, Andrea Stern Ferris, et al.. (2018). Making Lung Cancer Clinical Trials More Inclusive: Recommendations for Expanding Eligibility Criteria. Journal of Thoracic Oncology. 13(6). 748–751. 10 indexed citations
14.
Allen, Jeff, Mark Stewart, Samantha Roberts, & Ellen V. Sigal. (2017). The Value of Addressing Patient Preferences. Value in Health. 20(2). 283–285. 23 indexed citations
15.
Roberts, Samantha, et al.. (2016). Impact of breakthrough therapy designation on cancer drug development. Nature Reviews Drug Discovery. 15(3). 152–152. 30 indexed citations
16.
Horning, Sandra J., Daniel A. Haber, Wendy Selig, et al.. (2013). Developing Standards for Breakthrough Therapy Designation in Oncology. Clinical Cancer Research. 19(16). 4297–4304. 24 indexed citations
17.
Hayes, Daniel F., Jeff Allen, Carolyn C. Compton, et al.. (2013). Breaking a Vicious Cycle. Science Translational Medicine. 5(196). 196cm6–196cm6. 90 indexed citations
18.
Cleeland, Charles S., Jeff Allen, Samantha Roberts, et al.. (2012). Reducing the toxicity of cancer therapy: recognizing needs, taking action. Nature Reviews Clinical Oncology. 9(8). 471–478. 104 indexed citations
19.
Schilsky, Richard L., Jeff Allen, Joshua S. Benner, Ellen V. Sigal, & Mark McClellan. (2010). Commentary: Tackling the Challenges of Developing Targeted Therapies for Cancer. The Oncologist. 15(5). 484–487. 17 indexed citations
20.
Strader, Doris B., Bruce R. Bacon, Karen L. Lindsay, et al.. (2002). Use of complementary and alternative medicine in patients with liver disease. The American Journal of Gastroenterology. 97(9). 2391–2397. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroshi Ishiguro Breakdown of academic impact, for papers by Ariadna Tibau Breakdown of academic impact, for papers by Linyong Xu Breakdown of academic impact, for papers by Harald Enzmann Breakdown of academic impact, for papers by Kelloff Gj Breakdown of academic impact, for papers by Dinesh P. de Alwis Breakdown of academic impact, for papers by Brigitte Tranchand Breakdown of academic impact, for papers by John Duan Breakdown of academic impact, for papers by James Matcham Breakdown of academic impact, for papers by Connie M. Szczepanek
Rankless by CCL
2026